Log In
BCIQ
Print this Print this
 

Autologous umbilical cord blood

  Manage Alerts
Collapse Summary General Information
Company AMAG Pharmaceuticals Inc.
DescriptionAutologous umbilical cord blood stem cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$700.0M

$700.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/17/2015

$700.0M

$700.0M

0

Get a free BioCentury trial today